EXUMA Biotech is a clinical-stage biotechnology company that focuses on discovering and developing CAR-T cell products for solid tumors.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Exuma Biotech — Funding & Investors." VCBacked, December 21, 2021, https://www.vcbacked.co/company/exuma-biotech. Accessed July 2, 2026.
VCBacked. (2021). Exuma Biotech — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/exuma-biotech
{{cite web |title=Exuma Biotech — Funding & Investors |url=https://www.vcbacked.co/company/exuma-biotech |website=VCBacked |access-date=July 2, 2026}}Profile data sourced and verified per the VCBacked methodology. Last funding round dated .